Journal of the American College of Cardiology

Journal of the American College of Cardiology Journal

Publication venue for

Omega 3, Atrial Fibrillation, and Cardiovascular Outcomes. 82:E201-E202. 2023
Efficacy of Renal Denervation and Antihypertensives in Patients With Resistant Hypertension: A Systematic Review and Network Meta Analysis. 82:B292-B292. 2023
Endovascular Ultrasound Renal Denervation to Treat Uncontrolled Hypertension: 6-Month Results Following Blinded Medication Titration in the Randomized, Sham-Controlled RADIANCE II Pivotal Trial. 82:B159-B159. 2023
Prognostic Implications of Anemia in Impella-Supported HRPCI: Insights From the cVAD PROTECT III Study. 82:B55-B56. 2023
Relationship Between Preprocedural Blood Pressure and Outcomes in Patients Undergoing Impella-Supported High-Risk PCI: Insights From the cVAD PROTECT III Study. 82:B56-B57. 2023
Right Ventricular Function in Patients Undergoing ImpellaAssisted High-Risk Percutaneous Coronary Intervention: Insights From the cVAD PROTECT III Study. 82:B82-B83. 2023
(Left) Bundle Up! It's Getting Cold Out There in the Coronary Sinus. 82:242-244. 2023
Angiotensin-Neprilysin Inhibition in Heart Failure With Preserved Ejection Fraction. 82:13-15. 2023
Optimal Prevention of Cardiovascular Diseases The Earlier the Better. 81:1162-1164. 2023
Changes in Cardiorespiratory Fitness and Survival in Patients With or Without Cardiovascular Disease. 81:1137-1147. 2023
ESTIMATED POWER OUTPUT FOR STRENGTH TESTS AND MAXIMAL OXYGEN UPTAKE IN YOUNG ADULTS. 81:2277-2277. 2023
IMPACT OF RB-82 INFUSION PROFILE ON IMAGE QUALITY OF MYOCARDIAL PERFUSION IMAGES. 81:1453-1453. 2023
META-ANALYSIS COMPARING OUTCOMES OF REMOTE HEMODYNAMIC ASSESSMENT VERSUS STANDARD CARE IN PATIENTS WITH CHRONIC HEART FAILURE. 81:419-419. 2023
POST-PROCEDURAL PNEUMOPERICARDIUM. 81:3842-3842. 2023
TANDEM RESCUE: ADVANCED MECHANICAL CIRCULATORY SUPPORT IN A PATIENT WITH NO ADVANCED OPTIONS. 81:3282-3282. 2023
TRANSMITRAL FLOW RATE IN ASSESSING SEVERITY AND OUTCOMES IN MITRAL STENOSIS. 81:1990-1990. 2023
Long-Term Outcomes After Atrial Switch Operation for Transposition of the Great Arteries. 80:951-963. 2022
Fit Is It for Longevity Across Populations. 80:610-612. 2022
Carotid Artery Stenting JACC State-of-the-Art Review. 80:155-170. 2022
Trends in Clinical Presentation, Management, and Outcomes of STEMI in Patients With COVID-19. 79:2236-2244. 2022
NOT ALL MURMURS ARE BENIGN: AN ACUTE RUPTURE OF A SINUS OF VALSALVA ANEURYSM INTO THE RIGHT ATRIUM: A RARE COMPLICATION OF INFECTIVE ENDOCARDITIS. 79:2874-2874. 2022
RACE AND SEX-BASED DISPARITY IN CARE: WATCHMAN LEFT ATRIAL APPENDAGE OCCLUSION IN ATRIAL FIBRILLATION. 79:909-909. 2022
SUCCESSFUL EMBOLIZATION OF LAD ANEURYSM USING MULTIPLE HYDROCOILS. 79:2267-2267. 2022
North American COVID-19 Myocardial Infarction (NACMI) Risk Score for Prediction of In-Hospital Mortality. 78:B26-B26. 2021
Prasugrel or Clopidogrel in Patients With Acute Coronary Syndromes With Multivessel Disease: Results From the PROMETHEUS Study. 78:B93-B93. 2021
DETERMINING VALUE OF A CARDIOLOGY CLINIC VISIT. 77:1656-1656. 2021
IMPACT OF BASELINE LEFT VENTRICULAR EJECTION FRACTION ON OUTCOMES IN COVID-19 INFECTION. 77:3066-3066. 2021
MEASUREMENT OF THREE-DIMENSIONAL (3D) MITRAL VALVE AREA IN PATIENTS WITH MITRAL ANNULAR CALCIFICATION BY TRANSTHORACIC ECHOCARDIOGRAPHY. 77:1348-1348. 2021
MULTINATIONAL SURVEY ON MANAGEMENT OF PATIENTS WITH PATENT FORAMEN OVALE AND LEFT CIRCULATION THROMBOEMBOLISM. 77:1241-1241. 2021
Initial Findings From the North American COVID-19 Myocardial Infarction Registry. 77:1994-2003. 2021
Cardiac Injury in COVID-19-Echoing Prognostication. 76:2056-2059. 2020
A DELAYED DIAGNOSIS OF EOSINOPHILIC MYOCARDITIS AND PNEUMONITIS BY OPERATIVE BIOPSY DURING LVAD IMPLANTATION. 75:3343-3343. 2020
A Pesco-Mediterranean Diet With Intermittent Fasting JACC Review Topic of the Week. 76:1484-1493. 2020
BASELINE GLOBAL LEFT VENTRICULAR MYOCARDIAL WORK INDEX CAN PREDICT IMPROVEMENT IN EJECTION FRACTION IN PATIENTS WITH CLASSICAL LOW FLOW LOW GRADIENT AORTIC STENOSIS UNDERGOING TAVR. 75:1751-1751. 2020
CHANGES IN OXYGEN CONSUMPTION (NOT ANAEROBIC METABOLISM) DRIVE OUTCOMES AFTER EXERCISE THERAPY IN CARDIAC REHABILITATION. 75:1971-1971. 2020
Cardiovascular Effects of ADHD Therapies JACC Review Topic of the Week. 76:858-866. 2020
Expanding Traditional Cardiac Rehabilitation in the 21st Century. 75:1562-1564. 2020
Heart Failure With Preserved Ejection Fraction Separating the Wheat From the Chaff. 75:255-257. 2020
Heart Failure With Preserved Ejection Fraction The Quest for a Blood Pressure Goal. 75:1657-1658. 2020
INTRAVASCULAR HEMOLYSIS AS THE FIRST INDICATION OF MELODY VALVE FAILURE. 75:2800-2800. 2020
NOT ANOTHER PERIPARTUM CARDIOMYOPATHY! A COMPLICATED CASE OF ACUTE NECROTIZING EOSINOPHILIC MYOCARDITIS ASSOCIATED WITH UNCONTROLLED ASTHMA. 75:3345-3345. 2020
PERIVALVULAR ABSCESS PRESENTING AS REDUCTION IN DEGREE OF AORTIC STENOSIS. 75:2963-2963. 2020
POGO STICKING AND LVAD SQUEAKING! TORSION OF A HEARTMATE 3 OUTFLOW CANNULA AFTER JUMPING ON A POGO STICK. 75:3344-3344. 2020
PREDICTORS OF SUCCESSFUL OUTCOMES FOLLOWING CATHETER-BASED THERAPY FOR ACUTE STROKE BY INTERVENTIONAL CARDIOLOGISTS. 75:1146-1146. 2020
RESPONSE: COVID-19 and Challenges to Cardiovascular Graduate Medical Education. 76:1269-1269. 2020
SERIAL ECHOCARDIOGRAPHIC EVALUATION OF PATIENTS WITH DEGENERATIVE MITRAL STENOSIS UNDERGOING TAVR. 75:1778-1778. 2020
THE IMPACT OF HEMOGLOBIN ON RESTING MYOCARDIAL BLOOD FLOW MEASURED BY POSITRON EMISSION TOMOGRAPHY. 75:1678-1678. 2020
THE MAZE PROCEDURE IS A RISK FACTOR FOR LEFT ATRIAL THROMBUS. 75:374-374. 2020
TRANSIENT EFFUSIVE CONSTRICTIVE PERICARDITIS CAUSED BY E.COLI AND E.FAECIUM IN A PATIENT WITH A HISTORY OF ESOPHAGEAL ADENOCARCINOMA TREATED WITH SURGERY, CHEMOTHERAPY AND RADIATION. 75:2525-2525. 2020
30-Day Echocardiographic Assessment of Self-Expanding and Balloon-Expandable Valves After Valve-in-Valve Transcatheter Aortic Valve Replacement in Patients With Small Surgical Prostheses. 74:B746-B746. 2019
A CASE OF VALVE-IN-VALVE TRANSCATHETER VALVE REPLACEMENT IN BACTERIAL ENDOCARDITIS. 73:2993-2993. 2019
A TAVR AGAINST SEEMINGLY INSURMOUNTABLE ODDS. 73:2736-2736. 2019
Acute Stroke Intervention The Role of Interventional Cardiologists. 73:1491-1493. 2019
Bringing Cardiac Rehabilitation and Exercise Training to a Higher Level in Heart Failure. 73:1444-1446. 2019
DESPERATE TIMES REQUIRE DESPERATE MEASURES: A PATIENT PRESENTING WITH LEG PAIN. 73:2248-2248. 2019
DIFFERENCES IN OUTCOMES FOLLOWING BARE METAL OR DRUG ELUTING STENT PLACEMENT BEFORE TRANSCATHETER AORTIC VALVE REPLACEMENT IN THE ELDERLY. 73:1160-1160. 2019
Don't Do Something! Just Stand There. 73:2564-2566. 2019
EFFICACY AND SAFETY OF TRANSCAROTID TRANSCATHETER AORTIC VALVE REPLACEMENT IN 495 PATIENTS: A SYSTEMATIC REVIEW. 73:1374-1374. 2019
Exercise Intolerance in Patients With Heart Failure. 73:2209-2225. 2019
HDL and Heart Failure Regulation Still Breathing but Exhausted. 73:187-189. 2019
HIS BUNDLE PACING USING RETROGRADE MAPPING FOR A PATIENT WITH L-TRANSPOSITION OF GREAT ARTERIES. 73:2880-2880. 2019
MANAGEMENT OF HIGH ON-TREATMENT PLATELET REACTIVITY TO CLOPIDOGREL, PRASUGREL AND TICAGRELOR IN THE SAME PATIENT. 73:2911-2911. 2019
OPTIMIZING USE OF CARDIOVASCULAR IMAGING FOR DIAGNOSING INFECTIVE ENDOCARDITIS. 73:1616-1616. 2019
Quality Assurance for Carotid Stenting in the CREST-2 Registry. 74:3071-3079. 2019
Vascular Teams in Peripheral Vascular Disease. 73:2477-2486. 2019
2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials. 71:1021-1034. 2018
Axillary Intraaortic Balloon Pumps Reduces Time to Ambulation after Ventricular Assist Device or Transplant for Advanced Heart Failure. 72:B298-B298. 2018
CORONARY EMBOLISM AFTER LIPID RESCUE FOR BUPIVACAINE TOXICITY. 71:2141-2141. 2018
CORONARY REVASCULARIZATION-BASED IMPROVEMENT IN REGIONAL MYOCARDIAL BLOOD FLOW IS DEPENDENT ON BASELINE REGIONAL CORONARY FLOW CAPACITY. 71:1493-1493. 2018
Cookbook Medicine Is the Recipe for Successfully Managing Patients With PAD. 72:1012-1014. 2018
Dangers and Long-Term Outcomes in Metabolically Healthy Obesity The Impact of the Missing Fitness Component. 71:1866-1868. 2018
Elective Percutaneous Paravalvular Leak Closure Under Monitored Anesthesia Care: The Safety of Conscious Sedation with intra-procedural TEE for PVL Repair.. 72:B115-B115. 2018
FIRST IN HUMAN: THE EFFECTS OF BIVENTRICULAR PACING ON CARDIAC OUTPUT IN SEVERE PULMONARY HYPERTENSION. 71:1922-1922. 2018
Healthy Weight and Obesity Prevention JACC Health Promotion Series. 72:1506-1531. 2018
Healthy Weight and Obesity Prevention JACC Health Promotion Series (Reprinted from J Am Coll Cardiol, vol 72, pg 1506-31, 2018). 72:3027-3052. 2018
INDEPENDENT VALIDATION OF A CARDIORESPIRATORY FITNESS PREDICTION MODEL. 71:1878-1878. 2018
Impact of Physical Activity and Fitness in Metabolically Healthy Obesity. 71:812-813. 2018
PERCUTANEOUS ATRIAL SEPTAL DEFECTS CLOSURE IN ADULTS: DOUBLE VERSUS SINGLE DEVICE CLOSURE OF SECUNDUM DEFECTS - A META-ANALYSIS AND SYSTEMATIC REVIEW. 71:548-548. 2018
Placement of Axillary Intraaortic Balloon Pump Leads to Higher Adverse Event Rate When Compared to Placement of Femoral Intraaortic Balloon Pump. 72:B105-B105. 2018
Promoting Physical Activity and Exercise JACC Health Promotion Series. 72:1622-1639. 2018
Promoting Physical Activity and Exercise JACC Health Promotion Series (Reprinted from J Am Coll Cardiol, vol 72, pg 1622-39, 2018). 72:3053-3070. 2018
Psychopharmacology and Cardiovascular Disease. 71:2346-2359. 2018
REFRACTORY VENTRICULAR TACHYCARDIA FROM CORONARY VASOSPASM IN PREGNANCY. 71:2187-2187. 2018
Renal Denervation Improves Cardiac Function in a Swine Model of Heart Failure. 72:B14-B14. 2018
Renal Denervation Prevents Heart Failure Progression Via Inhibition of the Renin-Angiotensin System. 72:2609-2621. 2018
Sustained Physical Activity, Not Weight Loss, Associated With Improved Survival in Coronary Heart Disease. 71:1094-1101. 2018
USE OF AMIODARONE TO CONTROL ATRIAL FIBRILLATION CAUSED BY MECHANICAL COMPRESSION OF THE LEFT ATRIUM. 71:2546-2546. 2018
Adipose Composition and Heart Failure Prognosis Paradox or Not?. 70:2750-2751. 2017
Associations between Stent Diameter and Clinical Outcomes in ACS PCI Using Second Generation Drug-Eluting Stents: From the PROMETHEUS Study. 70:B316-B317. 2017
Carotid Artery Stenting Versus Endarterectomy for Stroke Prevention A Meta-Analysis of Clinical Trials. 69:2266-2275. 2017
Clinical Trial Principles and Endpoint Definitions for Paravalvular Leaks in Surgical Prosthesis An Expert Statement. 69:2067-2087. 2017
FITNESS AND THE OBESITY PARADOX IN CARDIAC REHABILITATION: HOW DOES WEIGHT LOSS FACTOR IN?. 69:1667-1667. 2017
HYPERTENSION CONTROL IS STRONGLY INFLUENCED BY PATIENT'S HEALTH CAPABILITY. 69:1838-1838. 2017
IMPROVING HEART FAILURE UNIT READMISSION PREDICTION. 69:773-773. 2017
Obesity and Atrial Fibrillation Prevalence, Pathogenesis, and Prognosis Effects of Weight Loss and Exercise. 70:2022-2035. 2017
Outcomes by Total Stent Length in ACS PCI with Second Generation Drug-Eluting Stents: Results from the PROMETHEUS Study. 70:B316-B316. 2017
REDUCED FLOW CAPACITY AS MEASURED BY CARDIAC POSITRON EMISSION TOMOGRAPHY PREDICTS VENTRICULAR TACHYARRHYTHMIA IN PATIENTS WITH AN ICD. 69:1607-1607. 2017
SEARCH FOR THE SUPER-RESPONDER: PROGRESSIVE INCREASES IN FITNESS AND AN ASSOCIATION WITH LOWER MORTALITY. 69:1732-1732. 2017
TRANSCATHETER AORTIC VALVE REPLACEMENT FOR AORTIC REGURGITATION AS A BRIDGE FOR COMBINED LIVER AND KIDNEY TRANSPLANTATION. 69:2189-2189. 2017
TRANSCATHETER AORTIC VALVE REPLACEMENT IN END STAGE LIVER DISEASE. 69:1219-1219. 2017
Transcaval Access and Closure for Transcatheter Aortic Valve Replacement A Prospective Investigation. 69:511-521. 2017
USE OF TANDEMHEART AS A BRIDGE TO SURGERY IN A PATIENT WITH COMBINED OBSTRUCTIVE AND CARDIOGENIC SHOCK DUE TO MECHANICAL MITRAL VALVE THROMBOSIS. 69:2354-2354. 2017
ACUTE PERICARDITIS FROM POST-OPERATIVE COMPLICATIONS OF PACEMAKER PLACEMENT AS A CAUSE FOR NEW-ONSET HEART FAILURE. 67:1075-1075. 2016
Acute Pulmonary Embolism With an Emphasis on an Interventional Approach. 67:991-1002. 2016
COMPARISON OF RIVAROXABAN OR WARFARIN USE FOR VENOUS THROMBOEMBOLISM ON INPATIENT LENGTH OF STAY. 67:2065-2065. 2016
Cardiac Rehabilitation and Healthy Life-Style Interventions Rectifying Program Deficiencies to Improve Patient Outcomes. 67:13-15. 2016
Critical Limb Ischemia An Expert Statement. 68:2002-2015. 2016
Dissection and Aneurysm in Patients With Fibromuscular Dysplasia Findings From the US Registry for FMD. 68:176-185. 2016
Genotype and Phenotype of Transthyretin Cardiac Amyloidosis THAOS (Transthyretin Amyloid Outcome Survey). 68:161-172. 2016
HOSPITAL READMISSIONS AMONG PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION TREATED WITH THE NEW ORAL ANTICOAGULANTS, APIXABAN, DABIGATRAN, AND RIVAROXABAN. 67:805-805. 2016
Peripheral Artery Disease Evolving Role of Exercise, Medical Therapy, and Endovascular Options. 67:1338-1338. 2016
Predicting In-Hospital Mortality in Patients With Acute Myocardial Infarction. 68:626-635. 2016
Predicting Persistent Left Ventricular Dysfunction Following Myocardial Infarction The PREDICTS Study. 67:1186-1196. 2016
Predictors of optimal medical therapy on discharge after percutaneous coronary intervention for acute coronary syndrome: An analysis of the PROMETHEUS registry. 68:B90-B90. 2016
Prevalence of prasugrel use and associations between type of acute coronary syndrome and 1-year clinical outcomes. 68:B42-B42. 2016
Relationship between anemia, prasugrel use and clinical outcomes in contemporary percutaneous coronary intervention for acute coronary syndromes. 68:B44-B45. 2016
Routine ECG Screening of Young Athletes Can This Strategy Ever Be Cost Effective?. 68:712-714. 2016
Sex-related differences in outcomes after percutaneous coronary intervention (PCI) in patients with diabetes presenting with acute coronary syndrome (ACS): Results from the PROMETHEUS study. 68:B110-B111. 2016
TELEMETRY OVERUSE AND ITS ECONOMIC IMPLICATIONS. 67:1993-1993. 2016
USE OF IMPELLA CP AS A BRIDGE TO RECOVERY IN TAKOTSUBO CARDIOMYOPATHY. 67:1043-1043. 2016
A META-ANALYSIS OF MULTI-VESSEL VERSUS CULPRIT ARTERY ONLY PERCUTANEOUS CORONARY INTERVENTION IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION. 65:A1768-A1768. 2015
COCATS 4 Securing the Future of Cardiovascular Medicine. 65:1907-1914. 2015
Cardiac Arrest A Treatment Algorithm for Emergent Invasive Cardiac Procedures in the Resuscitated Comatose Patient. 66:62-73. 2015
DETERMINATION OF LESION SEVERITY IN PATIENTS WITH PERIPHERAL ARTERIAL DISEASE: A COMPARISON OF COMPUTED TOMOGRAPHIC ANGIOGRAPHY TO CATHETER-BASED ANGIOGRAPHY WITH INTRAVASCULAR ULTRASOUND AS THE GOLD-STANDARD. 65:A2049-A2049. 2015
Evaluation and Treatment of Patients With Lower Extremity Peripheral Artery Disease Consensus Definitions From Peripheral Academic Research Consortium (PARC). 65:931-941. 2015
INCIDENCE OF PACEMAKER IMPLANTATION AND PARAVALVULAR AORTIC INSUFFICIENCY AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT: A COMPARISON OF THREE GENERATIONS OF EDWARDS SAPIEN VALVES. 65:A2034-A2034. 2015
Long Term Follow-up Meta-Analysis of Carotid Stenting Versus Endarterectomy: Different Procedures with a Similar Safety Profile. 66:B322-B322. 2015
Optimal Dose of Running for Longevity Is More Better or Worse?. 65:420-422. 2015
POSITRON EMISSION TOMOGRAPHY STRESS MYOCARDIAL BLOOD FLOW PREDICTS VENTRICULAR TACHYARRHYTHMIA IN PATIENTS WITH AN IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR. 65:A1149-A1149. 2015
PROPHYLACTIC INTRA-AORTIC BALLOON PUMP INSERTION PRIOR TO SURGICAL LEFT VENTRICULAR ASSIST DEVICE IMPLANTATION. 65:A889-A889. 2015
Proximal Balloon Occlusion versus Distal Filter Protection in Carotid Artery Stenting: A Meta-Analysis of Clinical Trial Data. 66:B33-B34. 2015
Surgical versus Endovascular Treatment for Acute Limb Ischemia: A Systematic Review and Meta-Analysis of Clinical Trials. 66:B325-B326. 2015
THE USE OF SPECKLE TRACKING STRAIN TO PREDICT RECOVERY OF LEFT VENTRICULAR FUNCTION AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT. 65:A1231-A1231. 2015
The Effect of Cardiorespiratory Fitness on Age-Related Lipids and Lipoproteins. 65:2091-2100. 2015
The Elephant in the Room: the Increased Incidence of Neurological Deficits with Carotid Endarterectomy Versus Protected Carotid Stenting in Randomized Controlled Trials. 66:B322-B323. 2015
BODY COMPOSITION AND SURVIVAL IN PATIENTS WITH SYSTOLIC HEART FAILURE AND UNDERLYING CORONARY HEART DISEASE. 63:A936-A936. 2014
BODY COMPOSITION, FITNESS AND ALL-CAUSE MORTALITY IN PA TIENTS WITH CORONARY HEART DISEASE FOLLOWING CARDIAC REHABILITATION. 63:A1276-A1276. 2014
CILOSTAZOL INCREASES PATENCY AND DECREASES ADVERSE OUTCOMES IN PATIENTS SUBMITTED TO PERCUTANEOUS FEMOROPOPLITEAL STENT REVASCULARIZATION: A RANDOMIZED CONTROLLED TRIALS META-ANALYSIS. 63:A2053-A2053. 2014
CORRELATION BETWEEN B-TYPE NATRIURETIC PEPTIDE LEVELS AND PULMONARY CAPILLARY WEDGE PRESSURE IN PATIENTS SUPPORTED WITH CONTINUOUS-FLOW LEFT VENTRICULAR ASIST DEVICES. 63:A890-A890. 2014
CORRELATION BETWEEN POSITRON EMISSION TOMOGRAPHY STRESS MYOCARDIAL BLOOD FLOW AND VENTRICULAR TACHYARRHYTHMIA OR DEATH IN PATIENTS WITH CARDIOMYOPATHY. 63:A293-A293. 2014
Carotid Artery Stenting. 64:723-731. 2014
Disparate Effects of Metabolically Healthy Obesity in Coronary Heart Disease and Heart Failure. 63:1079-1081. 2014
Echocardiographic Evaluation of Hemodynamics in Patients With Systolic Heart Failure Supported by a Continuous-Flow LVAD. 64:1231-1241. 2014
Effects of Cardiorespiratory Fitness on Blood Pressure Trajectory With Aging in a Cohort of Healthy Men. 64:1245-1253. 2014
Leisure-Time Running Reduces All-Cause and Cardiovascular Mortality Risk. 64:472-481. 2014
Longitudinal Algorithms to Estimate Cardiorespiratory Fitness Associations With Nonfatal Cardiovascular Disease and Disease-Specific Mortality. 63:2289-2296. 2014
Obesity and Cardiovascular Diseases. 63:1345-1354. 2014
PREDICTORS OF OUTCOMES WITH CATHETER-BASED THERAPY FOR ACUTE STROKE. 63:A1820-A1820. 2014
PROXIMAL EMBOLIC PROTECTION DECREASES CEREBRAL MICROEMBOLIZATION COMPARED TO DISTAL PROTECTION FOR CAROTID STENTING: A META-ANALYSIS. 63:A1826-A1826. 2014
THE EFFECT OF CORONARY REVASCULARIZATION ON MYOCARDIAL BLOOD FLOW AS ASSESSED BY PET-STRESS. 63:A1019-A1019. 2014
Vascular Brachytherapy versus Drug-Eluting Stents in the Treatment of In-Stent Restenosis: a Meta-Analysis of Long Term Outcomes. 64:B192-B193. 2014
Anatomic Versus Physiologic Assessment of Coronary Artery Disease. 62:1639-1653. 2013
Cardiovascular Care Facts. 62:1931-1947. 2013
Clinical Manifestations of Fibromuscular Dysplasia Vary by Patient Sex: A Report of the United States Registry for Fibromuscular Dysplasia. 62:2026-2028. 2013
Effects of Habitual Coffee Consumption on Cardiometabolic Disease, Cardiovascular Health, and All-Cause Mortality. 62:1043-1051. 2013
Lipid Control in the Modern Era An Orphan's Tale of Rags to Riches. 62:2185-2187. 2013
Niacin Therapy Lives for Another Day-Maybe?. 61:2197-2198. 2013
Sexual Function After Left Ventricular Assist Device. 61:2021-2022. 2013
Below-Knee Drug Eluting Stents Have Improved Patency, and Symptoms Compared to Bare Metal Stents: a meta-analysis. 60:B47-B47. 2012
Body Composition and Survival in Stable Coronary Heart Disease Impact of Lean Mass Index and Body Fat in the "Obesity Paradox". 60:1374-1380. 2012
COMPARISON OF TOTAL MEDICAL COST AVOIDANCE WITH THE USAGE OF NEW ORAL ANTICOAGULANTS INSTEAD OF WARFARIN AMONG ATRIAL FIBRILLATION PATIENTS, BASED ON THE ARISTOTLE, RE-LY AND ROCKET-AF TRIALS. 59:E599-E599. 2012
Changes in Fitness and Fatness on the Development of Cardiovascular Disease Risk Factors Hypertension, Metabolic Syndrome, and Hypercholesterolemia. 59:665-672. 2012
Exercise Training as Treatment of Depression in Heart Failure. 59:291-291. 2012
IS BODY FAT PROTECTIVE IN A POPULATION WITH PRESERVED EJECTION FRACTION?. 59:E1712-E1712. 2012
IS LEAN MASS PROTECTIVE IN PATIENTS WITH PRESERVED EJECTION FRACTION?. 59:E1785-E1785. 2012
LEFT ATRIAL VOLUME INDEX PREDICTS MORTALITY IN PATIENTS WITH NORMAL LEFT VENTRICULAR FILLING PRESSURE AND PRESERVED EJECTION FRACTION. 59:E1125-E1125. 2012
NATIONAL INSTITUTE OF HEALTH STROKE SCALE (NIHSS) SHOULD BE THE OUTCOME MEASURE OF CHOICE WHEN UTILIZING THE CARE REGISTRY. 59:E2130-E2130. 2012
Pre-procedural Risk Quantification for Carotid Stenting Using the CAS Score A Report From the NCDR CARE Registry. 60:1617-1622. 2012
A Prospective Study of Muscular Strength and All-Cause Mortality in Men With Hypertension. 57:1831-1837. 2011
Acute Stroke Treatment Carotid "Stenters" to the Rescue. 58:2370-2371. 2011
Another Step Forward in Refining Risk Stratification Moving Past Low-Density Lipoprotein Cholesterol. 58:464-466. 2011
BODY COMPOSITION AND SURVIVAL IN STABLE CORONARY HEART DISEASE: IMPACT OF LEAN MASS INDEX AND BODY FAT IN THE "OBESITY PARADOX". 57:E956-E956. 2011
BODY FAT AND MORTALITY IN PATIENTS WITH CORONARY HEART DISEASE: THE "OBESITY PARADOX" IS ALL IN THE FAT. 57:E570-E570. 2011
Carotid Artery Revascularization with Distal Protection in High Surgical Risk Patients in Routine Clinical Practice: Results of the CABANA Surety Surveillance Program. 58:B29-B29. 2011
Impact of Obesity on Outcomes in Myocardial Infarction. 58:2651-2653. 2011
LEAN MASS INDEX INDEPENDENTLY PREDICTS MORTALITY IN STABLE CORONARY HEART DISEASE. 57:E569-E569. 2011
REDUCING MEDICATION ERRORS IN DIALYSIS PATIENTS WITH ACUTE CORONARY SYNDROME USING COMPUTER-ASSISTED DECISION SUPPORT. 57:E1155-E1155. 2011
Stroke Intervention Catheter-Based Therapy for Acute Ischemic Stroke. 58:101-116. 2011
THE IMPACT OF ACHIEVING "PERFECT CARE" ON CARDIOVASCULAR OUTCOMES IN ACUTE CORONARY SYNDROME. 57:E1223-E1223. 2011
The Coalition to Reduce Racial and Ethnic Disparities in Cardiovascular Disease Outcomes (credo) Why credo Matters to Cardiologists. 57:245-252. 2011
Vitamin D and Cardiovascular Disease Will It Live Up to its Hype?. 58:1547-1556. 2011
Cardiac Rehabilitation, Exercise Training, and Anxiety. 56:1681-1682. 2010
Endovascular Stenting for Vertebral Artery Stenosis. 55:538-542. 2010
Proximal Embolic Protection A "Game Changer" for Carotid Stents. 55:1668-1670. 2010
The Role of Omega-3 Fatty Acids in Primary Prevention of Coronary Artery Disease and in Atrial Fibrillation Is Controversial Reply. 55:411-412. 2010
Vertebral Artery Stenting Not Quite Ready for Prime Time! Reply. 56:320-320. 2010
Beta-Blockers as First-Line Antihypertensive Therapy The Crumbling Continues. 54:1162-1164. 2009
Impact of Left Atrial Volume Index and Left Ventricular Geometry on Mortality in Obese Versus Nonobese Elderly Patients With Preserved Ejection Fraction. 53:A238-A238. 2009
Left Atrial Volume Index and Left Ventricular Geometry Independently Predict Mortality in 16,904 Elderly Patients With Preserved Ejection Fraction. 53:A273-A273. 2009
Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss. 53:1925-1932. 2009
Omega-3 Polyunsaturated Fatty Acids and Cardiovascular Diseases. 54:585-594. 2009
The Obesity Paradox in Coronary Heart Disease-Does Body Fat Complete the Puzzle?. 53:A227-A227. 2009
Carotid artery revascularization in high-surgical-risk patients using the Carotid WALLSTENT and FilterWire EX/EZ. 51:427-434. 2008
Combating the obesity paradox - Benefits and safety of purposeful weight loss in overweight and obese coronary patients. 51:A367-A367. 2008
Safety of carotid artery stent placement in the elderly. 51:B75-B75. 2008
Shedding light on high-density lipoprotein cholesterol - The post-ILLUMINATE era. 51:56-58. 2008
Subclavian and innominate artery stent placement for symptomatic patients: Three-year follow-up. 51:A314-A314. 2008
The eye as an indicator of heart failure in diabetic patients. 51:1579-1580. 2008
Ventricular-arterial interactions predict survival in 6,762 patients with left ventricular hypertrophy and preserved ejection fraction. 51:A132-A132. 2008

International Standard Serial Number (ISSN)

0735-1097